dipeptidyl peptidase I inhibitors (Arpida)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedipeptidyl peptidase I inhibitors (Arpida)
Drug Alias Namecathepsin C inhibitors (Arpida)dipeptidyl peptidase I inhibitors (Combio)DPPI inhibitors (Arpida)DPPI inhibitors (Combio)cathepsin C inhibitors (Combio) +[7] 
ClassificationSmall molecules
Mechanisms of ActionCathepsin C inhibitors
TargetsCathepsin C
Therapy Area/IndicationsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvolva
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvolvaEvolva Holding Sa
Active IndicationsN/A
Inactive IndicationsSepsis

Other Information

ATC CodeN/A
Related LinksN/A